Oral and Oropharyngeal Cancer: What’s New? + Biopsy Workshop
Oral and Oropharyngeal Cancer: What’s New? + Biopsy Workshop
09:00 a.m. - 01:00 p.m.
This year, according to the American Cancer Society, approximately 58,000 new cases of oral and oropharyngeal cancer are expected in the United States and oropharyngeal cancer continues to be on the rise. As dentists, we play an important role in the early detection and prevention of oral cancer. This workshop provides an overview on the epidemiology of oral and oropharyngeal cancer, their clinical manifestation, diagnosis, treatment options and oral complications of cancer therapy.
You will have the opportunity to see multiple cases of patients with oral and oropharyngeal cancer and learn about implications for the dental community. In addition, participants will be able to perform oral biopsy techniques.
You Will Learn
- To examine the epidemiology of oral and oropharyngeal cancer (including HPV-associated oropharyngeal cancer)
- To identify the clinical presentation and management options of oral and oropharyngeal cancer
- To recognize early and late oral complications from cancer therapy
- To describe the current management strategies for patients with oral toxicities secondary to head and neck cancer therapy
- To understand the role of the dentist in the cancer management team
- To implement current oral biopsy techniques
Who Should Attend
This workshop is designed for dentists and dental specialists.
Early Bird Tuition: $445 (for registrations received by September 26)
Regular Tuition: $495
Program: 9:00 am – 1:00 pm
Location: Arthur A. Dugoni School of Dentistry, 155 Fifth Street, SF
Credits: This activity is designated for 4 units of continuing education credit.
Workshop is limited to 30 participants; includes morning coffee/tea service.
Presenter
Alessandro Villa, DDS, PhD, MPH, is chief of oral medicine, oral oncology and dentistry at Miami Cancer Institute – Baptist Health South Florida and a professor at the Herbert Wertheim College of Medicine at Florida International University. Previously, he was chief of oral medicine at University of California, San Francisco (UCSF). He also directed the oral medicine residency programs at UCSF and Harvard. Dr. Villa’s research focuses on oral dysplasia and oral complications from cancer therapy. He works closely with several organizations to reduce the incidence of Human Papilloma Virus (HPV)-related cancers. He has authored more than 140 peer-reviewed articles.